Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
DXB.AX
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Sales Growth
YoY
Current
Estimates
Return on Equity
QoQ
Institutionnal Ownership
Q2.20
N/A
-0.01
vs -0.01
Q4.20
N/A
-0.02
vs -0.02
Q2.21
N/A
-0.01
vs -0.01
Q4.21
N/A
-0.02
vs -0.02
Q2.22
N/A
-0.01
vs -0.01
Q4.22
N/A
-0.03
vs -0.02
Q2.23
N/A
-0.01
vs -0.01
Q4.23
N/A
-0.02
vs -0.03
Q2.24
N/A
-0.02
vs -0.01
Q4.24
N/A
-0.02
vs -0.02
Q2.20
+97%
2.3M vs 1.2M
Q4.20
+7240%
130.6K vs 1.8K
Q2.21
+84%
4.3M vs 2.3M
Q4.21
-100%
NA vs 130.6K
Q2.22
+50%
6.5M vs 4.3M
Q4.22
NA
NA vs NA
Q2.23
+39%
9M vs 6.5M
Q4.23
NA
133.1K vs NA
Q2.24
-95%
450.4K vs 9M
Q4.24
+116%
287.4K vs 133.1K
Q2.21
-143%
-1.43
vs -1.21
Q4.21
-35%
-0.35
vs -1.43
Q2.22
-28%
-0.28
vs -0.35
Q4.22
-198%
-1.98
vs -0.28
Q2.23
-70%
-0.70
vs -1.98
Q4.23
-389%
-3.89
vs -0.70
Q2.24
-57%
-0.57
vs -3.89
Q4.24
-180%
-1.80
vs -0.57
Relative Strength
DXB.AX
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
2648%2025-Revenue
-29%2025-EPS
40%2025-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs. It develops DMX-200 that is in two Phase 3 clinical trials for COVID respiratory complications; DMX-200, a Phase 3 clinical trial for focal segmental glomerulosclerosis disease; DMX-200 for diabetic kidney disease; and DMX-700 for chronic obstructive pulmonary disease. The company is headquartered in Fitzroy, Australia.
ASX
Unprofitable
Unprofitable
-0.01Â ( -0.88%)
Relative Strenght
Volume Buzz
-47%
Earning Acce
No
Dist 52w H.
29%Quote Panel
Key Metrics
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How DXB.AX compares to sector?